Iran's National Institute of Genetic Engineering and Biotechnology (NIGEB) has developed an anti-cancer vaccine that will be ...

It’s not the first time Johnson’s pursuit of immortality has made the news. The 47-year-old allegedly spends about $2 million ...

The Saline versus Albumin Fluid Evaluation (SAFE) study was a randomized, double-blind comparison of saline and albumin in a heterogeneous population of intensive care unit patients. The study ...

Using this evidence-based approach, Johnson claims he replaced his old plasma with a mixture of five percent albumin, a blood protein, and intravenous immunoglobulin (IVIG), a fluid derived from ...

The tech millionaire said he would like to donate the plasma as it could aid in a 'whole range of health therapies.' ...

Groundbreaking research exposes how diabetes damages kidneys, offering hope through early detection and innovative prevention ...

I am no longer injecting my son's blood. I've upgraded to something else: total plasma exchange,” the biotech entrepreneur announced.

Company completed Type C meeting with FDA, aligning on its plan to submit an sNDA; submission expected around end of 1Q25If approved, FILSPARI ...